Täuber M G, Kunz S, Zak O, Sande M A
Department of Medicine, University Hospital, Zurich, Switzerland.
Antimicrob Agents Chemother. 1989 Apr;33(4):418-23. doi: 10.1128/AAC.33.4.418.
We examined the influence of several pharmacokinetic parameters on cure rates in rabbits with experimental pneumococcal meningitis. When the duration of treatment was kept constant, cure rates improved as the individual dose of ampicillin was increased. On the other hand, when four doses of ampicillin at 60 mg/kg of body weight, producing peak concentrations in cerebrospinal fluid (CSF) of approximately 40 times the MBC, were administered at intervals of 24 instead of 4 h and the duration of therapy was thus prolonged from 12 to 72 h, cure rates also increased (85 versus 25%; P less than 0.01). These high cure rates were achieved even though bacterial titers in CSF 24 h after the first dose had reached levels similar to those present at the beginning of therapy. Cure in these animals was explained by the fact that the second ampicillin dose reduced bacterial titers in CSF significantly more than did the first dose (5.2 versus 2.5 log10 CFU/ml; P less than 0.02). The clinical relevance of these observations remains to be determined.
我们研究了几个药代动力学参数对实验性肺炎球菌脑膜炎家兔治愈率的影响。当治疗时间保持恒定时,随着氨苄西林单次剂量的增加,治愈率提高。另一方面,当给予四剂60mg/kg体重的氨苄西林,使脑脊液(CSF)中的峰值浓度达到约最低杀菌浓度(MBC)的40倍,给药间隔为24小时而非4小时,从而使治疗时间从12小时延长至72小时时,治愈率也有所提高(85%对25%;P<0.01)。即便在首剂后24小时脑脊液中的细菌滴度已达到与治疗开始时相似的水平,仍实现了这些高治愈率。这些动物的治愈可解释为第二个氨苄西林剂量使脑脊液中的细菌滴度降低幅度显著大于第一个剂量(5.2对2.5 log10 CFU/ml;P<0.02)。这些观察结果的临床相关性仍有待确定。